Severe eosinophilia and subsequent dermatologic immune‐related adverse event with squamous cell carcinoma antigen elevation induced by nivolumab and ipilimumab

Immune checkpoint inhibitors (ICIs) for malignant lesions are associated with immune‐related adverse events (irAEs), but reports about severe eosinophilia induced by ICIs are scarce. A 73‐year‐old man with lung squamous cell carcinoma was treated by chemotherapy (carboplatin plus paclitaxel) and ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Takeshi, Kaneko, Akiko, Kusakabe, Yusuke, Nakayama, Emi, Tanaka, Ayaka, Yamamoto, Naoki, Aihara, Kensaku, Yamaoka, Shinpachi, Mishima, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459412/
https://www.ncbi.nlm.nih.gov/pubmed/36176718
http://dx.doi.org/10.1002/rcr2.1037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459412/
https://www.ncbi.nlm.nih.gov/pubmed/36176718
http://dx.doi.org/10.1002/rcr2.1037

Ejemplares similares